Comparison of risk factors during 12 months, intensive prevention program versus usual care.
| . | Beginning of study . | 12 months . |
|---|---|---|
| LDL cholesterol, mg/dl | ||
| MV ± SD | ||
| – IPP | 73.1 ± 26 | 67.6 ± 21*,# |
| – UC | 73.8 ± 26 | 78.4 ± 29 |
| Total cholesterol, mg/dl | ||
| MV ± SD | ||
| – IPP | 146.7 ± 30 | 143.2 ± 26# |
| – UC | 145.5 ± 28 | 153.3 ± 34* |
| Systolic blood pressure, mmHg | ||
| MV ± SD | ||
| – IPP | 133 ± 17 | 130 ± 15*,# |
| – UC | 132 ± 16 | 135 ± 18* |
| Diastolic blood pressure, mmHg | ||
| MV ± SD | ||
| – IPP | 80 ± 10 | 79 ± 9 |
| – UC | 81 ± 10 | 82 ± 12 |
| Body mass index, kg/m2 | ||
| MV ± SD | ||
| – IPP | 28.1 ± 3.8 | 28.0 ± 4.0 |
| – UC | 27.9 ± 3.7 | 28.3 ± 4.2* |
| HbA1c in diabetics, % | ||
| MV ± SD | ||
| – IPP | 6.7 ± 0.8 | 6.9 ± 0.7 |
| – UC | 6.7 ± 0.8 | 7.3 ± 1.8 |
| . | Beginning of study . | 12 months . |
|---|---|---|
| LDL cholesterol, mg/dl | ||
| MV ± SD | ||
| – IPP | 73.1 ± 26 | 67.6 ± 21*,# |
| – UC | 73.8 ± 26 | 78.4 ± 29 |
| Total cholesterol, mg/dl | ||
| MV ± SD | ||
| – IPP | 146.7 ± 30 | 143.2 ± 26# |
| – UC | 145.5 ± 28 | 153.3 ± 34* |
| Systolic blood pressure, mmHg | ||
| MV ± SD | ||
| – IPP | 133 ± 17 | 130 ± 15*,# |
| – UC | 132 ± 16 | 135 ± 18* |
| Diastolic blood pressure, mmHg | ||
| MV ± SD | ||
| – IPP | 80 ± 10 | 79 ± 9 |
| – UC | 81 ± 10 | 82 ± 12 |
| Body mass index, kg/m2 | ||
| MV ± SD | ||
| – IPP | 28.1 ± 3.8 | 28.0 ± 4.0 |
| – UC | 27.9 ± 3.7 | 28.3 ± 4.2* |
| HbA1c in diabetics, % | ||
| MV ± SD | ||
| – IPP | 6.7 ± 0.8 | 6.9 ± 0.7 |
| – UC | 6.7 ± 0.8 | 7.3 ± 1.8 |
Data are mean values ± standard deviations (MV ± SD).
LDL: low-density lipoprotein; IPP: intensive prevention programme; UC: usual care.
p < 0.05 vs. beginning of study.
#p < 0.05 vs. control cohort (usual care).
Comparison of risk factors during 12 months, intensive prevention program versus usual care.
| . | Beginning of study . | 12 months . |
|---|---|---|
| LDL cholesterol, mg/dl | ||
| MV ± SD | ||
| – IPP | 73.1 ± 26 | 67.6 ± 21*,# |
| – UC | 73.8 ± 26 | 78.4 ± 29 |
| Total cholesterol, mg/dl | ||
| MV ± SD | ||
| – IPP | 146.7 ± 30 | 143.2 ± 26# |
| – UC | 145.5 ± 28 | 153.3 ± 34* |
| Systolic blood pressure, mmHg | ||
| MV ± SD | ||
| – IPP | 133 ± 17 | 130 ± 15*,# |
| – UC | 132 ± 16 | 135 ± 18* |
| Diastolic blood pressure, mmHg | ||
| MV ± SD | ||
| – IPP | 80 ± 10 | 79 ± 9 |
| – UC | 81 ± 10 | 82 ± 12 |
| Body mass index, kg/m2 | ||
| MV ± SD | ||
| – IPP | 28.1 ± 3.8 | 28.0 ± 4.0 |
| – UC | 27.9 ± 3.7 | 28.3 ± 4.2* |
| HbA1c in diabetics, % | ||
| MV ± SD | ||
| – IPP | 6.7 ± 0.8 | 6.9 ± 0.7 |
| – UC | 6.7 ± 0.8 | 7.3 ± 1.8 |
| . | Beginning of study . | 12 months . |
|---|---|---|
| LDL cholesterol, mg/dl | ||
| MV ± SD | ||
| – IPP | 73.1 ± 26 | 67.6 ± 21*,# |
| – UC | 73.8 ± 26 | 78.4 ± 29 |
| Total cholesterol, mg/dl | ||
| MV ± SD | ||
| – IPP | 146.7 ± 30 | 143.2 ± 26# |
| – UC | 145.5 ± 28 | 153.3 ± 34* |
| Systolic blood pressure, mmHg | ||
| MV ± SD | ||
| – IPP | 133 ± 17 | 130 ± 15*,# |
| – UC | 132 ± 16 | 135 ± 18* |
| Diastolic blood pressure, mmHg | ||
| MV ± SD | ||
| – IPP | 80 ± 10 | 79 ± 9 |
| – UC | 81 ± 10 | 82 ± 12 |
| Body mass index, kg/m2 | ||
| MV ± SD | ||
| – IPP | 28.1 ± 3.8 | 28.0 ± 4.0 |
| – UC | 27.9 ± 3.7 | 28.3 ± 4.2* |
| HbA1c in diabetics, % | ||
| MV ± SD | ||
| – IPP | 6.7 ± 0.8 | 6.9 ± 0.7 |
| – UC | 6.7 ± 0.8 | 7.3 ± 1.8 |
Data are mean values ± standard deviations (MV ± SD).
LDL: low-density lipoprotein; IPP: intensive prevention programme; UC: usual care.
p < 0.05 vs. beginning of study.
#p < 0.05 vs. control cohort (usual care).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
